COMMUNIQUÉS West-GlobeNewswire

-
Mereo BioPharma Group plc Announces Positive Early 6 Month Data from the Open Label Arm of the Phase 2b Clinical Study in Adult Patients with Type I, III or IV Osteogenesis Imperfecta Treated with the Anti-Sclerostin Antibody, BPS-804 (setrusumab)
30/05/2019 -
Novartis' phase III QUARTZ study of new investigational inhaled combination treatment QMF149 meets primary and key secondary endpoints in patients with inadequately controlled asthma
30/05/2019 -
BrainStorm Announces Second Clinical Site to Enroll Patients in Its Progressive MS Phase 2 Study
30/05/2019 -
Mesoblast Initiates Rolling Submission of Biologics License Application (BLA) to U.S. FDA for remestemcel-L in the Treatment of Acute Graft Versus Host Disease
30/05/2019 -
Helix BioPharma Corp. Closes Private Placement
30/05/2019 -
Indus Holdings, Inc. Reports Record Revenue in the First Quarter 2019 Financial Results
30/05/2019 -
Eve & Co Announces Second German Supply Agreement; Provides Update on First German Supply Agreement
29/05/2019 -
GILEAD AND GALAPAGOS TO PRESENT LATEST DATA ON FILGOTINIB AT THE ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY (EULAR 2019)
29/05/2019 -
electroCore Announces Comprehensive Redeployment and Cost Reduction Plan
29/05/2019 -
Aptose Announces Proposed Public Offering of Common Shares
29/05/2019 -
Xenon Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference
29/05/2019 -
Myovant Sciences Announces $100 Million Public Offering of Common Shares
29/05/2019 -
Supernus to Present at the Jefferies 2019 Global Healthcare Conference
29/05/2019 -
Kane Biotech to Showcase Technologies and Products at the 2019 BIO International Convention
29/05/2019 -
Amicus Therapeutics Announces Public Offering of Common Stock
29/05/2019 -
BioDelivery Sciences Announces Upcoming Investor Conference Presentations
29/05/2019 -
Synthorx to Present at Jefferies 2019 Healthcare Conference
29/05/2019 -
Bellicum Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference
29/05/2019 -
Guardant Health to Present at the William Blair 2019 Growth Stock Conference
29/05/2019
Pages